Results 1 to 10 of about 4,746,761 (313)
Harm reduction--the cannabis paradox. [PDF]
Harm Reduction Journal, 2005 AbstractThis article examines harm reduction from a novel perspective. Its central thesis is that harm reduction is not only a social concept, but also a biological one. More specifically, evolution does not make moral distinctions in the selection process, but utilizes a cannabis-based approach to harm reduction in order to promote survival of the ...
Robert J. Melamede
openalex +5 more sources
For a renewed harm reduction model. [PDF]
Harm Reduct JIn the early 1990s, the spread of HIV among heroin injectors prompted a shift in drug policy internationally, including in France. This led to the emergence of a new policy known as Harm Reduction (HR) and related tools, including needle exchange programmes, opioid substitution therapy programmes to manage illicit opiate consumption, as well as ...
Chappard P, Pourchon F.
europepmc +4 more sources
Harm reduction or harm maintenance? [PDF]
Nicotine & Tobacco Research, 2002 John P. Pierce
openalex +4 more sources
Harm reduction in hospitals: is it time? [PDF]
Harm Reduction Journal, 2009 Abstract Among persons who inject drugs (IDU), illicit drug use often occurs in hospitals and contributes to patient expulsion and/or high rates of leaving against medical advice (AMA) when withdrawal is inadequately managed. Resultant disruptions in medical care may increase the likelihood of several harms including drug resistance to ...
Beth Rachlis +3 more
openalex +7 more sources
Sociotechnical Harms of Algorithmic Systems: Scoping a Taxonomy for Harm Reduction [PDF]
AAAI/ACM Conference on AI, Ethics, and Society, 2022 Understanding the landscape of potential harms from algorithmic systems enables practitioners to better anticipate consequences of the systems they build. It also supports the prospect of incorporating controls to help minimize harms that emerge from the
R. Shelby +10 more
semanticscholar +1 more source
Harm Reduction Journal, 2023 Introduction Xylazine, an α2-adrenoceptor agonist sedative commonly used in veterinary medicine, is not approved for human use. Nevertheless, xylazine-involved overdose rates have surged in recent years, fueled by an increasingly toxic and synthetic ...
David T. Zhu
semanticscholar +1 more source
A scoping review of implementation considerations for harm reduction vending machines
Harm Reduction Journal, 2023 Background Community-based harm reduction vending machines (HRVM) are not new to the field of public health; numerous countries have implemented them in response to the needs of people who use drugs over the last three decades.
Erin Russell +6 more
semanticscholar +1 more source
Gambling harm prevention and harm reduction in online environments: a call for action
Harm Reduction Journal, 2023 Background Gambling is increasingly offered and consumed in online and mobile environments. The digitalisation of the gambling industry poses new challenges on harm prevention and harm reduction.
V. Marionneau +2 more
semanticscholar +1 more source
Harm Reduction Journal, 2023 Background The COVID-19 pandemic worsened the ongoing overdose crisis in the United States (US) and caused significant mental health strain and burnout among health care workers (HCW). Harm reduction, overdose prevention, and substance use disorder (SUD)
I. C. Unachukwu +6 more
semanticscholar +1 more source